遠隔医療と遠隔治療市場：コンポーネント別、提供形態別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界の遠隔医療と遠隔治療の市場規模は、予測期間の2024年～2031年のCAGRが15.47%に達し、2023年の1,096億1,000万米ドルから2031年には3,464億4,000万米ドルに成長すると予測されています。同市場の成長を支えているのは、慢性疾患数の増加、ヘルスケア部門の拡大、ヘルスケアのデジタル化、遠隔医療・遠隔治療技術の様々な利点に対する意識の高まり、政府の取り組みの強化などです。

製品の利用を強化するための政府の取り組みの増加は、世界の遠隔医療と遠隔治療市場の重要な動向の一つです。2023年11月、フランスの国有鉄道会社は、2028年までに300の鉄道駅に遠隔医療サービスを展開すると発表しました。選択された駅は、十分なヘルスケアが提供されていない共同開発や優先介入ゾーンにあります。このような投資は市場需要を促進し、今後数年間の市場拡大にプラスの影響を与えると予想されます。

遠隔医療や遠隔治療の採用も、がん治療に関連する温室効果ガス排出を削減する技術の能力のおかげで増加すると予想されます。2024年6月にJAMA Oncology誌に発表された研究によると、分散化されたがん治療によって排出量の大幅な削減が見られました。このコホート研究では、患者123,890人が160万日以上の受診を行いましたが、遠隔医療ケアモデルでは、受診日1日当たりの排出量が対面ケアモデルと比較して81.3％削減されました。分散型ケア（可能な場合は遠隔医療も含む）と通常ケアを比較した全国的な反実仮想モデルでは、排出量が33.1％削減されました。このコホート研究は、遠隔医療はがん医療によって発生する温室効果ガスの排出を大幅に削減する可能性があると結論づけました。

当レポートでは、世界の遠隔医療と遠隔治療市場について調査し、市場の概要とともに、コンポーネント別、提供形態別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の遠隔医療と遠隔治療市場の見通し、2017年～2031年

• 市場規模と予測
• コンポーネント別
• 提供形態別
• 用途別
• エンドユーザー別
• 地域別
• 企業別市場シェア（％）、2023年

第5章 世界の遠隔医療と遠隔治療市場の見通し、地域別、2017年～2031年

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

• 供給需要分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 イノベーション/新興技術

第10章 主要参入企業の情勢

第11章 ケーススタディ

第12章 主要参入企業の見通し

• Koninklijke Philips N.V.
• Veradigm LLC
• Medtronic, plc
• Siemens Healthineers AG
• Cisco Systems, Inc.
• Oracle Healthcare Private Limited
• GE HealthCare Technologies, Inc.
• Teladoc Health, Inc.
• MDLIVE Inc.
• American Well Corporation

第13章 戦略的提言

第14章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 3. Global Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 4. Global Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 5. Global Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 6. Global Telehealth and Telemedicine Market Share (%), By Region, 2017-2031F
• Figure 7. North America Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 8. North America Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 9. North America Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 10. North America Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 11. North America Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 12. North America Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
• Figure 13. United States Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 14. United States Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 15. United States Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 16. United States Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 17. United States Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 18. Canada Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 19. Canada Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 20. Canada Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 21. Canada Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 22. Canada Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 23. Mexico Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 24. Mexico Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 25. Mexico Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 26. Mexico Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 27. Mexico Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 28. Europe Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 29. Europe Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 30. Europe Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 31. Europe Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 32. Europe Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
• Figure 34. Germany Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 35. Germany Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 36. Germany Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 37. Germany Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 38. Germany Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 39. France Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 40. France Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 41. France Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 42. France Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 43. France Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 44. Italy Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 45. Italy Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 46. Italy Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 47. Italy Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 48. Italy Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 49. United Kingdom Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 50. United Kingdom Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 51. United Kingdom Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 52. United Kingdom Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 53. United Kingdom Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 54. Russia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 55. Russia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 56. Russia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 57. Russia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 58. Russia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 59. Netherlands Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 60. Netherlands Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 61. Netherlands Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 62. Netherlands Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 63. Netherlands Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 64. Spain Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 65. Spain Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 66. Spain Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 67. Spain Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 68. Spain Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 69. Turkey Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 70. Turkey Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 71. Turkey Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 72. Turkey Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 73. Turkey Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 74. Poland Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 75. Poland Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 76. Poland Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 77. Poland Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 78. Poland Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 79. South America Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 80. South America Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 81. South America Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 82. South America Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 83. South America Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 84. South America Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
• Figure 85. Brazil Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 86. Brazil Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 87. Brazil Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 88. Brazil Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 89. Brazil Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 90. Argentina Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 91. Argentina Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 92. Argentina Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 93. Argentina Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 94. Argentina Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 95. Asia-Pacific Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 96. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 97. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 98. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 99. Asia-Pacific Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 100. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
• Figure 101. India Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 102. India Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 103. India Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 104. India Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 105. India Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 106. China Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 107. China Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 108. China Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 109. China Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 110. China Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 111. Japan Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 112. Japan Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 113. Japan Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 114. Japan Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 115. Japan Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 116. Australia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 117. Australia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 118. Australia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 119. Australia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 120. Australia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 121. Vietnam Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 122. Vietnam Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 123. Vietnam Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 124. Vietnam Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 125. Vietnam Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 126. South Korea Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 127. South Korea Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 128. South Korea Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 129. South Korea Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 130. South Korea Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 131. Indonesia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 132. Indonesia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 133. Indonesia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 134. Indonesia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 135. Indonesia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 136. Philippines Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 137. Philippines Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 138. Philippines Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 139. Philippines Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 140. Philippines Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 141. Middle East & Africa Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 142. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 143. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 144. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 145. Middle East & Africa Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 146. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
• Figure 147. Saudi Arabia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 148. Saudi Arabia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 149. Saudi Arabia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 150. Saudi Arabia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 151. Saudi Arabia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 152. UAE Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 153. UAE Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 154. UAE Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 155. UAE Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 156. UAE Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 157. South Africa Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
• Figure 158. South Africa Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
• Figure 159. South Africa Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
• Figure 160. South Africa Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
• Figure 161. South Africa Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
• Figure 162. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163. By Mode of Delivery Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global telehealth and telemedicine market is projected to witness a CAGR of 15.47% during the forecast period 2024-2031, growing from USD 109.61 billion in 2023 to USD 346.44 billion in 2031F. The market's growth is supported by the rise in the number of chronic diseases, expansion of the healthcare sector, digitization of healthcare, growing awareness about the various advantages of telehealth and telemedicine technologies and increasing government efforts.

The rise in government efforts to bolster product utilization is one of the crucial global telehealth and telemedicine market trends. In November 2023, the national railway company of France announced that it would deploy telemedicine services by 2028 across 300 train stations. The selected stations are in concerted development and priority intervention zones that do not have sufficient healthcare offerings. Such investments are expected to propel the market demand and positively influence the expansion of the market in the coming years.

The adoption of telehealth and telemedicine is also anticipated to increase owing to the ability of the technologies to reduce greenhouse gas emissions associated with cancer care. According to a study published in JAMA Oncology in June 2024, a substantial reduction of emissions was witnessed with decentralized cancer care. In the cohort study that included 123,890 patients seen over 1.6 million visit days, the telemedicine care model reduced per-visit day emissions by 81.3% compared to the in-person care model. In the national counterfactual model, which compared decentralized care (local site care as well as telemedicine when possible) and usual care, a reduction of 33.1% in emissions was witnessed. The cohort study concluded that telehealth has the potential to reduce the greenhouse gas emissions generated by cancer care substantially.

Rising Collaborations to Drive the Global Telehealth and Telemedicine Market

The rise in collaborations between various healthcare companies to enhance access to different healthcare facilities in order to improve patient outcomes is expected to support the growth of the market. For instance, in June 2024, Infosys Technologies Private Limited announced partnerships with NIHON CHOUZAI Co., Ltd. and developed a mobile application for NiCOMS, allowing patients to receive medication guidance from pharmacists remotely. With this collaboration, the companies aim to enhance medical services and boost access to high-quality pharmaceutical interventions in Japan. Such developments are anticipated to enhance patient comfort by allowing patients to connect with healthcare professionals and conveniently receive medication and disease management instructions.

Rising Awareness About Advantages Associated with Telehealth and Telemedicine

The increasing awareness about the different advantages associated with the utilization of telehealth and telemedicine products and services is expected to provide lucrative growth opportunities to the market. The utilization of telehealth and telemedicine aids in providing individuals with mobility limitations access to healthcare. Meanwhile, in the case of chronic condition management, telemedicine allows the patient to connect with the doctor or other healthcare professional and aids in forming long term relationships and also get counseling and mental health assessment in case of requirement in a seamless manner.

The time and cost efficiency offered by these technologies are also bolstering their usage in different regions across the globe. According to a study published in JAMA Network in January 2023, telehealth was associated with savings in travel costs and patient time and can aid in the economic burden associated with treatments. The study included 11,688 patients with 25,496 telehealth visits and showcased that telehealth accounted for an estimated savings of USD 467,247 in lost income due to visit time and USD 11,70,160 in lost income due to driving time.

North America Accounts for a Significant Share in Global Telehealth and Telemedicine Market Share

The market growth in the region is aided by the rising prevalence of different chronic conditions, the expanding healthcare sector, and increasing investments in healthcare IT. According to the American Cancer Society, in 2024, 611,720 cancer-related deaths and 2,001,140 new cases are estimated to occur in the United States. This increase bolsters the utilization of telehealth and telemedicine technologies as they aid the caretakers of patients with advanced cancer in providing quality care to their patients by reducing the burden associated with regular hospital visits. They also aid patients in reducing various indirect costs associated with regular doctor visits, including travel expenses and loss of income due to taking time off work to accommodate medical visits and travel. Due to the advantages of telehealth and telemedicine and the increasing acceptance of remote consultation, the market is witnessing significant growth in North America in the coming years.

Software Segment Expected to Witness Significant Growth

The software segment is expected to witness significant growth in the coming years owing to the various advantages associated with their usage, including safety, convenience, and cost efficiency. Software helps effectively manage chronic diseases, monitor different health conditions, and ensure adherence to medication is practiced. Additionally, the segment's growth is also supported by the rising investments by various companies towards upgrading their software to enhance the quality of care provided to patients, propelling the global telehealth and telemedicine market. In June 2024, telehealth company TytoCare Ltd. announced that it was releasing an update for its Home Smart Clinic software to allow patients access to urgent, primary, and specialty care and make the telehealth experience seamless. The update will also increase the number of healthcare providers patients can connect with, allow patients to record vital data before the visit, and provide a link for every appointment, which will be rolled out to the patients and providers in the coming months.

Future Market Scenario (2024-2031F)

According to the global telehealth and telemedicine market analysis, the requirement for telehealth and telemedicine is expected to increase significantly over the forecast period owing to their ability to streamline the workflow of clinics and hospitals, which is becoming essential as the population expands and the prevalence of chronic diseases increases. These technologies often emphasize high-value tasks and reduce the burden associated with patient check-ins while providing coverage to individuals in rural locations with limited treatment and consultation options.

A rise in research and development activities will also support market growth. For instance, an interventional study, which is expected to conclude in October 2024, is being conducted to evaluate how telehealth exercises aid in enhancing cardiovascular health in lymphoma survivors. Meanwhile, an interventional study is also being conducted to evaluate whether telemedicine follow-ups for patients with leg ulcers and diabetes-related foot ulcers are a viable alternative to traditional follow-ups. The study is expected to conclude in December 2024.

Key Players Landscape and Outlook

The growth of the market is boosted by the increasing collaborations between the key market players and insurance benefits and assistance service companies. For instance, in June 2024, International Medical Group, Inc. and Teladoc Health, Inc. announced the expansion of their partnership. This partnership will expand the International Medical Group's offerings of telehealth services with the utilization of Teladoc's All360Health, an easy-to-use platform available for prescription and telehealth services. With this platform travelers can connect with healthcare experts across the globe via online video and phone consultations. Such partnerships are expected to aid the market players in expanding their customer base and boost the global telehealth and telemedicine market size.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Telehealth and Telemedicine Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. By Component
  • 4.2.1. Software
    • 4.2.1.1. Integrated Software
    • 4.2.1.2. Standalone Software
  • 4.2.2. Hardware
    • 4.2.2.1. Monitors
    • 4.2.2.2. Medical Peripheral Devices
      • 4.2.2.2.1. Blood Pressure Meters
      • 4.2.2.2.2. Blood Glucose Meters
      • 4.2.2.2.3. Peak Flow Meters
      • 4.2.2.2.4. ECG Monitors
      • 4.2.2.2.5. Pulse Oximeters
      • 4.2.2.2.6. Weighing Scales
      • 4.2.2.2.7. Others
  • 4.2.3. Services
• 4.3. By Mode of Delivery
  • 4.3.1. On-premise
  • 4.3.2. Cloud-based
• 4.4. By Application
  • 4.4.1. Teleconsultation
  • 4.4.2. Remote Patient Monitoring
  • 4.4.3. Telepathology
  • 4.4.4. Telepsychiatry
  • 4.4.5. Teledermatology
  • 4.4.6. Others
• 4.5. By End-user
  • 4.5.1. Payers
    • 4.5.1.1. Private
    • 4.5.1.2. Public
  • 4.5.2. Providers
    • 4.5.2.1. Hospitals and Clinics
    • 4.5.2.2. Assisted Living Centers and Long-Term Care Centers
  • 4.5.3. Patients
• 4.6. By Region
  • 4.6.1. North America
  • 4.6.2. South America
  • 4.6.3. Europe
  • 4.6.4. Asia-Pacific
  • 4.6.5. Middle East and Africa
• 4.7. By Company Market Share (%), 2023

5. Global Telehealth and Telemedicine Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
  • 5.1.2. By Component
    • 5.1.2.1. Software
      • 5.1.2.1.1. Integrated Software
      • 5.1.2.1.2. Standalone Software
    • 5.1.2.2. Hardware
      • 5.1.2.2.1. Monitors
      • 5.1.2.2.2. Medical Peripheral Devices
        • 5.1.2.2.2.1. Blood Pressure Meters
        • 5.1.2.2.2.2. Blood Glucose Meters
        • 5.1.2.2.2.3. Peak Flow Meters
        • 5.1.2.2.2.4. ECG Monitors
        • 5.1.2.2.2.5. Pulse Oximeters
        • 5.1.2.2.2.6. Weighing Scales
        • 5.1.2.2.2.7. Others
    • 5.1.2.3. Services
  • 5.1.3. By Mode of Delivery
    • 5.1.3.1. On-premise
    • 5.1.3.2. Cloud-based
  • 5.1.4. By Application
    • 5.1.4.1. Teleconsultation
    • 5.1.4.2. Remote Patient Monitoring
    • 5.1.4.3. Telepathology
    • 5.1.4.4. Telepsychiatry
    • 5.1.4.5. Teledermatology
    • 5.1.4.6. Others
  • 5.1.5. By End-user
    • 5.1.5.1. Payers
      • 5.1.5.1.1. Private
      • 5.1.5.1.2. Public
    • 5.1.5.2. Providers
      • 5.1.5.2.1. Hospitals and Clinics
      • 5.1.5.2.2. Assisted Living Centers and Long-Term Care Centers
    • 5.1.5.3. Patients
  • 5.1.6. United States*
    • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
    • 5.1.6.2. By Component
      • 5.1.6.2.1. Software
        • 5.1.6.2.1.1. Integrated Software
        • 5.1.6.2.1.2. Standalone Software
      • 5.1.6.2.2. Hardware
        • 5.1.6.2.2.1. Monitors
        • 5.1.6.2.2.2. Medical Peripheral Devices
        • 5.1.6.2.2.2.1. Blood Pressure Meters
        • 5.1.6.2.2.2.2. Blood Glucose Meters
        • 5.1.6.2.2.2.3. Peak Flow Meters
        • 5.1.6.2.2.2.4. ECG Monitors
        • 5.1.6.2.2.2.5. Pulse Oximeters
        • 5.1.6.2.2.2.6. Weighing Scales
        • 5.1.6.2.2.2.7. Others
      • 5.1.6.2.3. Services
    • 5.1.6.3. By Mode of Delivery
      • 5.1.6.3.1. On-premise
      • 5.1.6.3.2. Cloud-based
    • 5.1.6.4. By Application
      • 5.1.6.4.1. Teleconsultation
      • 5.1.6.4.2. Remote Patient Monitoring
      • 5.1.6.4.3. Telepathology
      • 5.1.6.4.4. Telepsychiatry
      • 5.1.6.4.5. Teledermatology
      • 5.1.6.4.6. Others
    • 5.1.6.5. By End-user
      • 5.1.6.5.1. Payers
        • 5.1.6.5.1.1. Private
        • 5.1.6.5.1.2. Public
      • 5.1.6.5.2. Providers
        • 5.1.6.5.2.1. Hospitals and Clinics
        • 5.1.6.5.2.2. Assisted Living Centers and Long-Term Care Centers
        • 5.1.6.5.2.3. Patients
  • 5.1.7. Canada
  • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East and Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Component
• 6.2. By Mode of Delivery
• 6.3. By Application
• 6.4. By End-user
• 6.5. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Value Chain Analysis
• 7.3. PESTEL Analysis
  • 7.3.1. Political Factors
  • 7.3.2. Economic System
  • 7.3.3. Social Implications
  • 7.3.4. Technological Advancements
  • 7.3.5. Environmental Impacts
  • 7.3.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.4. Porter's Five Forces Analysis
  • 7.4.1. Supplier Power
  • 7.4.2. Buyer Power
  • 7.4.3. Substitution Threat
  • 7.4.4. Threat from New Entrant
  • 7.4.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Case Studies

12. Key Players Outlook

• 12.1. Koninklijke Philips N.V.
  • 12.1.1. Company Details
  • 12.1.2. Key Management Personnel
  • 12.1.3. Products and Services
  • 12.1.4. Financials (As reported)
  • 12.1.5. Key Market Focus and Geographical Presence
  • 12.1.6. Recent Developments
• 12.2. Veradigm LLC
• 12.3. Medtronic, plc
• 12.4. Siemens Healthineers AG
• 12.5. Cisco Systems, Inc.
• 12.6. Oracle Healthcare Private Limited
• 12.7. GE HealthCare Technologies, Inc.
• 12.8. Teladoc Health, Inc.
• 12.9. MDLIVE Inc.
• 12.10. American Well Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

13. Strategic Recommendations

14. About Us & Disclaimer